文献速递慢性肾脏病

胱抑素C与肌酐估算GFR不一致的复杂病因及其不良关联:CRIC研究结果

Complex Etiologies of the Discordance Between Cystatin C- and Creatinine-Based Estimated GFR and Its Adverse Associations: Findings From the CRIC Study.
PubMed 文献 · Am J Kidney Dis · 2025-05-13

在1290例有直接测量GFR的CRIC研究成人CKD参与者中,eGFRdiff(eGFRcys-eGFRcr)更正值与全因死亡(校正HR 0.80)和心衰住院(校正HR 0.83)风险降低相关,调整eGFRdiff的推定决定因素后关联无实质变化;这些因素仅解释eGFRdiff变异的36%。

要点

  • eGFRdiff更正值与死亡风险降低相关(校正HR 0.80,95%CI 0.74-0.88)。
  • 肌肉量等推定决定因素仅解释eGFRdiff变异的36%,关联调整后无实质变化。

核心结论

  • eGFRdiff与不良结局的关联在调整肌肉量等推定决定因素后无实质变化。
  • 所检验的eGFRdiff推定决定因素仅解释eGFRdiff变异的一小部分(36%)。

研究设计与样本

  • 前瞻性队列研究分析eGFRdiff与结局,横断面研究分析eGFRdiff决定因素。
  • 纳入CRIC研究中1290例有直接测量碘海醇GFR、24小时尿肌酐收集及血浆β2微球蛋白等大分子测量的成人参与者。

主要发现

  • eGFRdiff更正值与死亡风险降低相关(校正HR 0.80,95%CI 0.74-0.88)。
  • 调整eGFRdiff推定决定因素后上述关联无实质变化。
  • eGFRdiff与肌肉量标志物、中分子清除及其他推定决定因素(如肥胖、炎症)仅弱相关。
  • 这些因素仅解释eGFRdiff变异的36%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 24小时尿液收集等测量存在不精确性。
  • 需要进一步研究以揭示这些关联背后的病理生理机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: The difference between glomerular filtration rate (GFR) estimated by cystatin C and creatinine (eGFRdiff, defined as eGFRcys-eGFRcr) has been repeatedly associated with adverse outcomes, often ascribed to low muscle mass. However, it is unclear to what extent putative determinants of eGFRdiff, such as low muscle mass, explain associations between eGFRdiff and the outcomes of death and heart failure. Determinants of eGFRdiff have not been investigated to assess their impacts on eGFRcys, eGFRcr, and ultimately eGFRdiff in a dataset with measured GFR. STUDY DESIGN: Prospective cohort study for outcomes of eGFRdiff and cross-sectional study for determinants of eGFRdiff. SETTING & PARTICIPANTS: 1,290 adult participants in the Chronic Renal Insufficiency Cohort (CRIC) Study with directly measured iothalamate GFR, 24-hour urine creatinine collections, and plasma measurements of larger molecules such as β2-microglobulin. EXPOSURE: Baseline eGFRdiff (eGFRcys-eGFRcr) for prospective analysis; putative eGFRdiff determinants for cross-sectional analyses. OUTCOME: Time to all-cause death, heart failure hospitalization for prospective analyses, and eGFR for cross-sectional analyses. ANALYTICAL APPROACH: Cox proportional hazards regression for prospective analysis and linear regression for cross-sectional analyses. RESULTS: Among adults with CKD, a more positive eGFRdiff was associated with decreased risk of death (adjusted HR, 0.80 [95% CI, 0.74-0.88]) and heart failure hospitalization (adjusted HR 0.83 [95% CI, 0.73-94]). Neither association was substantially changed by adjustment for putative determinants of eGFRdiff. Estimated GFRdiff was weakly correlated with markers of muscle mass, middle molecule clearance, and other putative determinants of eGFRdiff (eg, obesity, inflammation). Only 36% of the variance in eGFRdiff was explained by these factors. LIMITATIONS: Imprecision in measurements such as 24-hour urine collections. CONCLUSIONS: The associations of eGFRdiff with adverse outcomes were unchanged by adjustment for markers of putative determinants such as muscle mass. Examined putative determinants of eGFRdiff accounted for a minority of the variance in eGFRdiff. PLAIN-LANGUAGE SUMMARY: The difference between estimated glomerular filtration rates (eGFRdiff) using serum creatinine and cystatin C (eGFRcys-eGFRcr) has been repeatedly associated with adverse outcomes, including death and heart failure. The biological mechanisms underlying eGFRdiff are unclear. In this study of adult patients with CKD, we found that adjustment for these proposed causes of eGFRdiff, including measures of muscle mass and protein intake (daily urine creatinine excretion) and kidney clearance of larger molecules (β2-microglobulin and β-trace protein levels relative to measured GFR), did not change the associations between eGFRdiff and subsequent adverse outcomes. Only 36% of the variance in eGFRdiff was accounted for by the proposed causes. Further research is needed to uncover the pathophysiology behind these associations.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. McCoy IE, Yang J, Go AS, et al. Complex Etiologies of the Discordance Between Cystatin C- and Creatinine-Based Estimated GFR and Its Adverse Associations: Findings From the CRIC Study. Am J Kidney Dis. 2025. PMID: 40373998. doi:10.1053/j.ajkd.2025.03.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。